KLRC1 and neoplasm: Chronic IFNγ signalling consistently induced expression of Qa-1b/HLA-E, a ligand for the cytotoxic lymphocyte inhibitory receptor NKG2a/CD94, in mouse tumour models, thereby conferring resistance to α-PD-1 therapy10.